Scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient. This simple and innovative test provides clinicians with the ability to track the function of these…

Click here to view the original article.